Skip to main content

Zolpidem Tartrate Extended-Release Tablets

Type of Posting: Revision Bulletin

Posting Date: 27–Jan–2012

Official Date: 01–Feb–2012

Expert Committee: Monographs—Small Molecules 4

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised Zolpidem Tartrate Extended-Release Tablets monograph. The purpose for the revision is as follows:

  • Revise the tolerance for 240 min pull time in Dissolution, Test 1 to NLT 90% to be consistent with FDA approved specifications.
  • Add Dissolution Test 4 for product approved by FDA.

This Zolpidem Tartrate Extended-Release Tablets Revision Bulletin supersedes the currently official Zolpidem Tartrate Extended-Release Tablets monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 35–NF 30.

Should you have any questions, please contact Hari Ramanathan, M.S. (301-816-8313 or hr@usp.org).